Clinical Trials Logo

Clinical Trial Summary

This study is a multicenter, randomized trial for the treatment of subjects discharging from the hospital with a chest tube and valve in place. Subjects will be randomized to receive oral antibiotics and close monitoring, defined as twice weekly telephone calls by a member of the care team, of their chest tube and valve or standard of care, defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped.


Clinical Trial Description

This study is a multicenter, randomized trial for the treatment of subjects discharging from the hospital with a chest tube and valve in place. Subjects will be screened prior to discharging from the hospital and interested qualified subjects will be consented and offered participation in this trial. Once consent has been obtained the subject will be randomized to receive oral antibiotics and close monitoring, defined as twice weekly telephone calls by a member of the care team, of their chest tube and valve or standard of care, defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped. The subject will be followed until they have their chest tube removed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03943511
Study type Interventional
Source Mayo Clinic
Contact
Status Enrolling by invitation
Phase N/A
Start date October 7, 2019
Completion date September 2025

See also
  Status Clinical Trial Phase
Completed NCT02491671 - Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection Phase 3
Active, not recruiting NCT06356038 - Phrenic Nerve Infiltration: Pulmonary Expansion and Pain Control N/A
Completed NCT01166516 - IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study N/A
Completed NCT04065880 - Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation N/A